Saturday, February 15, 2025
News

Obinutuzumab trial yields promising outcomes in patients with lupus nephritis

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

California | November 11, 2023 12:22:57 AM IST
Researchers discovered that obinutuzumab, an antibody that targets a protein expressed on certain immune cells, was superior to placebo in preserving kidney function and preventing flares in patients with lupus nephritis - a kidney condition associated with the autoimmune disease lupus.

The study was published in Arthritis & Rheumatology, an official journal of the American College of Rheumatology, and is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of rheumatic diseases.

The journal publishes the highest-quality basic and clinical research related to rheumatic diseases, encompassing a wide range of areas of investigative activity.

Researchers found that adding obinutuzumab to lupus nephritis treatment lowered the probability of developing a composite outcome of mortality, decline in kidney function, or treatment failure by 60 per cent when compared to standard-of-care treatment alone.

Over the course of the trial, adding obinutuzumab lowered the incidence of lupus nephritis relapses by 57 per cent and dramatically reduced the rate of deterioration in kidney function.

Overall, 38 per cent of obinutuzumab-treated patients compared with 16 per cent of placebo-treated patients achieved complete remission of lupus nephritis by week 76, with the need for fewer glucocorticoids.

"These data are really important because the ultimate goal of lupus nephritis therapy is to preserve kidney survival so patients never have to face the need for dialysis or transplantation because their kidneys failed," said corresponding author Brad Rovin, MD, of Ohio State University Wexner Medical Center.

"The addition of obinutuzumab to standard lupus nephritis therapy may increase the likelihood of achieving this goal." (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
'Our challenge is to make healthcare mor...
Researchers discover new type of Brain c...
Burn care gets a boost: AIIMS Bhubaneswa...
Intestinal-womb connection successfully ...
Guillain-Barre Syndrome Syndrome: Mumbai...
Hand of Hope: 38-year-old's life transfo...
More...
 
INDIA WORLD ASIA
Northern Railway to run Vande Bharat spe...
Baijayant Panda to chair Select Committe...
Maharashtra CM assures to establish dyna...
Congress stalwart Ahmed Patel's son Fais...
Students carrying CBSE Admit Cards will ...
Railway Board's Hitendra Malhotra review...
More...    
 
 Top Stories
US Army to no longer allow transgen... 
Israel: Thousands of immigrants nee... 
UAE: Al Zeyoudi engages with senior... 
"Don't know what will happen tomorr... 
2 accused in Fairplay money launder... 
White House bans Associated Press f... 
Tripura: BSF nabs five Bangladeshis... 
Maharashtra Govt orders inquiry by ...